231 related articles for article (PubMed ID: 17024740)
1. N-acetylcysteine and contrast-induced nephropathy.
Balderramo DC
N Engl J Med; 2006 Oct; 355(14):1498-9; author reply 1499-500. PubMed ID: 17024740
[No Abstract] [Full Text] [Related]
2. N-acetylcysteine and contrast-induced nephropathy in primary angioplasty.
Marenzi G; Assanelli E; Marana I; Lauri G; Campodonico J; Grazi M; De Metrio M; Galli S; Fabbiocchi F; Montorsi P; Veglia F; Bartorelli AL
N Engl J Med; 2006 Jun; 354(26):2773-82. PubMed ID: 16807414
[TBL] [Abstract][Full Text] [Related]
3. N-acetylcysteine and contrast-induced nephropathy.
Ritz E
N Engl J Med; 2006 Oct; 355(14):1499; author reply 1499-500. PubMed ID: 17024738
[No Abstract] [Full Text] [Related]
4. N-acetylcysteine somewhere between Scylla and Charybdis.
Sochman J
J Am Coll Cardiol; 2010 Sep; 56(13):1067; author reply 1067-8. PubMed ID: 20846610
[No Abstract] [Full Text] [Related]
5. N-acetylcysteine and contrast-induced nephropathy.
Wolak A; Cafri C; Zahger D
N Engl J Med; 2006 Oct; 355(14):1498; author reply 1499-500. PubMed ID: 17024739
[No Abstract] [Full Text] [Related]
6. The value of hydration and acetylcysteine in the prevention of contrast-induced nephropathy: a potentially catastrophic complication of the percutaneous coronary interventions.
Iyisoy A; Celik T; Yuksel UC; Bugan B; Isik E
Int J Cardiol; 2009 May; 134(3):431-3; author reply 434. PubMed ID: 18501445
[TBL] [Abstract][Full Text] [Related]
7. Sodium bicarbonate, N-acetylcysteine, and saline for the prevention of contrast-induced nephropathy.
Bouzas-Mosquera A; Recio-Mayoral A
Am Heart J; 2008 Apr; 155(4):e31. PubMed ID: 18371455
[No Abstract] [Full Text] [Related]
8. [Management of renal complications during primary angioplasty].
Marenzi G; Marana I; Bartorelli A
Recenti Prog Med; 2007; 98(7-8):367-72. PubMed ID: 17685183
[TBL] [Abstract][Full Text] [Related]
9. Contrast-induced nephropathy remains a serious complication of PCI.
Mehran R
J Interv Cardiol; 2007 Jun; 20(3):236-40. PubMed ID: 17524117
[No Abstract] [Full Text] [Related]
10. Contrast-induced acute kidney injury. Underappreciated or a new marker of cardiovascular mortality?
Mehran R; Brar S; Dangas G
J Am Coll Cardiol; 2010 May; 55(20):2210-1. PubMed ID: 20466201
[No Abstract] [Full Text] [Related]
11. N-acetylcysteine for prevention of radiocontrast induced nephrotoxicity: the importance of dose and route of administration.
Shalansky SJ; Pate GE; Levin A; Webb JG
Heart; 2005 Aug; 91(8):997-9. PubMed ID: 16020580
[TBL] [Abstract][Full Text] [Related]
12. High-dose N-acetylcysteine for the prevention of contrast-induced nephropathy.
Trivedi H; Daram S; Szabo A; Bartorelli AL; Marenzi G
Am J Med; 2009 Sep; 122(9):874.e9-15. PubMed ID: 19699385
[TBL] [Abstract][Full Text] [Related]
13. Does N-acetylcysteine reduce the incidence of contrast-induced nephropathy and clinical events in patients undergoing primary angioplasty for acute myocardial infarction?
Tanaka A; Suzuki Y; Suzuki N; Hirai T; Yasuda N; Miki K; Fujita M; Tanaka T
Intern Med; 2011; 50(7):673-7. PubMed ID: 21467697
[TBL] [Abstract][Full Text] [Related]
14. Acetylcysteine and non-ionic isosmolar contrast-induced nephropathy--a randomized controlled study.
Ferrario F; Barone MT; Landoni G; Genderini A; Heidemperger M; Trezzi M; Piccaluga E; Danna P; Scorza D
Nephrol Dial Transplant; 2009 Oct; 24(10):3103-7. PubMed ID: 19549691
[TBL] [Abstract][Full Text] [Related]
15. Sodium bicarbonate, N-acetylcysteine, and saline for prevention of radiocontrast-induced nephropathy. A comparison of 3 regimens for protecting contrast-induced nephropathy in patients undergoing coronary procedures. A single-center prospective controlled trial.
Ozcan EE; Guneri S; Akdeniz B; Akyildiz IZ; Senaslan O; Baris N; Aslan O; Badak O
Am Heart J; 2007 Sep; 154(3):539-44. PubMed ID: 17719303
[TBL] [Abstract][Full Text] [Related]
16. Hemofiltration in the prevention of radiocontrast agent induced nephropathy.
Marenzi G; Bartorelli AL
Minerva Anestesiol; 2004 Apr; 70(4):189-91. PubMed ID: 15173694
[TBL] [Abstract][Full Text] [Related]
17. N-acetylcysteine for prevention of radiographic contrast material-induced nephropathy: is the intravenous route best?
Shalansky SJ; Vu T; Pate GE; Levin A; Humphries KH; Webb JG
Pharmacotherapy; 2005 Aug; 25(8):1095-103. PubMed ID: 16207100
[TBL] [Abstract][Full Text] [Related]
18. Contrast medium-induced nephropathy: strategies for prevention.
Massicotte A
Pharmacotherapy; 2008 Sep; 28(9):1140-50. PubMed ID: 18752385
[TBL] [Abstract][Full Text] [Related]
19. Evidence-based management of patients undergoing PCI: contrast-induced acute kidney injury.
Caixeta A; Mehran R
Catheter Cardiovasc Interv; 2010 Mar; 75 Suppl 1():S15-20. PubMed ID: 20333702
[TBL] [Abstract][Full Text] [Related]
20. N-acetylcysteine use to prevent contrast medium-induced nephropathy: premature phase III trials.
Stenstrom DA; Muldoon LL; Armijo-Medina H; Watnick S; Doolittle ND; Kaufman JA; Peterson DR; Bubalo J; Neuwelt EA
J Vasc Interv Radiol; 2008 Mar; 19(3):309-18. PubMed ID: 18295688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
